Is There Still a Role for Digoxin in the Management of Atrial Fibrillation?
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is There Still a Role for Digoxin in the Management of Atrial Fibrillation?
Authors
Keywords
Digoxin, Atrial fibrillation
Journal
Current Cardiology Reports
Volume 20, Issue 11, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-12
DOI
10.1007/s11886-018-1047-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Digoxin and Mortality in Patients With Atrial Fibrillation
- (2018) Renato D. Lopes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
- (2018) Naqash J. Sethi et al. PLoS One
- Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial
- (2017) Alon Eisen et al. Journal of the American Heart Association
- Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation
- (2016) Waqas Qureshi et al. Cardiology Journal
- Rate-Control Treatment and Mortality in Atrial FibrillationCLINICAL PERSPECTIVE
- (2015) Tze-Fan Chao et al. CIRCULATION
- Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation
- (2015) Daniele Pastori et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort
- (2015) Larry A. Allen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
- (2015) Jeffrey B Washam et al. LANCET
- Interaction Between Digoxin and Dronedarone in the PALLAS Trial
- (2014) Stefan H. Hohnloser et al. Circulation-Arrhythmia and Electrophysiology
- Digoxin in patients with permanent atrial fibrillation: Data from the RACE II study
- (2014) Bart A. Mulder et al. HEART RHYTHM
- Increased Mortality Associated With Digoxin in Contemporary Patients With Atrial Fibrillation
- (2014) Mintu P. Turakhia et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial
- (2013) M. Gheorghiade et al. EUROPEAN HEART JOURNAL
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased mortality among patients taking digoxin--analysis from the AFFIRM study
- (2012) M. G. Whitbeck et al. EUROPEAN HEART JOURNAL
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF)
- (2009) L. Friberg et al. HEART
- Digitalis: a dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data
- (2007) K Gjesdal et al. HEART
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search